MSR176 Q-Squared as a Mapping Model Performance Metric in Gastrointestinal Disease
Mallon K. et al, (2025), Value in Health, 28
MSR199 The HERC Database of Mapping Studies: A 2025 Update of a Live Systematic Review of Studies Predicting EQ-5D From Other Patient-Reported Outcome Measures
Mallon K. et al, (2025), Value in Health, 28, s534 - s535
Improving outcomeS for Women diagnosed with early breast cancer through adhErence to adjuvant Endocrine Therapy (SWEET): study protocol for a pragmatic Randomised Control Trial of a patient-centred intervention to improve adherence to endocrine therapy in early breast cancer
Mcgeagh L. et al, (2025), Trials
Supporting women with adherence to adjuvant endocrine therapy (SWEET): feasibility study of the HT&Me intervention.
McGeagh L. et al, (2025), Eur J Oncol Nurs, 80
Stereotactic radiotherapy for nAMD: areas for improvement - Authors' reply.
Jackson TL. et al, (2025), Lancet, 406, 26 - 27
How are maternal and fetal outcomes incorporated when measuring benefits of interventions in pregnancy? Findings from a systematic review of cost-utility analyses.
Abel L. et al, (2024), Health and Quality of Life Outcomes
Estimating Risk Factor Time Paths Among People with Type 2 Diabetes and QALY Gains from Risk Factor Management.
Gao N. et al, (2024), Pharmacoeconomics, 42, 1017 - 1028
Using QALYs as an outcome for assessing global prediction accuracy in diabetes simulation models
DAKIN H. et al, (2024), Medical decision making
Using orthopaedic health care resources efficiently: A cost analysis of day surgery for unicompartmental knee replacement.
Hlatshwako TG. et al, (2024), Knee, 49, 147 - 157
Stereotactic radiotherapy for neovascular age-related macular degeneration (STAR): a pivotal, randomised, double-masked, sham-controlled device trial.
Jackson TL. et al, (2024), Lancet, 404, 44 - 54
Rationing in an era of multiple tight constraints: Is cost-utility analysis still fit for purpose?
DAKIN H. and TSIACHRISTAS A., (2024), Applied Health Economics and Health Policy
CALIBRATION OF A PATIENT-LEVEL SIMULATION MODEL FOR DIABETES IN THE ABSENCE OF PATIENT-LEVEL DATA: A PROPOSED METHOD AND HEALTH ECONOMIC IMPLICATIONS
Tran-Duy A. et al, (2024), VALUE IN HEALTH, 27, S7 - S7
Health Poverty among people with Type 2 Diabetes Mellitus (T2DM) in Malaysia
Parra-Mujica F. et al, (2023), Social Science and Medicine
Trends in all-cause mortality among adults with diagnosed type 2 diabetes in West Malaysia: 2010 - 2019.
Lim L-L. et al, (2023), Diabetes Res Clin Pract, 205
Cost-effectiveness of replacing versus discarding the nail in children with nail bed injury.
Dakin HA. et al, (2023), Br J Surg, 110, 1104 - 1107
Effectiveness of nail bed repair in children with or without replacing the fingernail: the NINJA multicentre randomised controlled trial
JAIN A. et al, (2023), British Journal of Surgery
Cost-effectiveness of adalimumab for early-stage Dupuytren's disease : an economic evaluation based on a randomized controlled trial and individual-patient simulation model.
Dakin H. et al, (2022), Bone Jt Open, 3, 898 - 906